Last reviewed · How we verify
Treatment 1. Metoclopramide — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Treatment 1. Metoclopramide (Treatment 1. Metoclopramide) — Hamad Medical Corporation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Treatment 1. Metoclopramide TARGET | Treatment 1. Metoclopramide | Hamad Medical Corporation | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Treatment 1. Metoclopramide CI watch — RSS
- Treatment 1. Metoclopramide CI watch — Atom
- Treatment 1. Metoclopramide CI watch — JSON
- Treatment 1. Metoclopramide alone — RSS
Cite this brief
Drug Landscape (2026). Treatment 1. Metoclopramide — Competitive Intelligence Brief. https://druglandscape.com/ci/treatment-1-metoclopramide. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab